Last reviewed · How we verify
NCT06763705
Comparison of Safety and Efficacy for Different Sedation Regimens During Colonoscopy
Phase 4 trial testing Midazolam in Deep Sedations in 157 participants. Currently enrolling.
15 December 2025
Quick facts
| Lead sponsor | Qassim Health Cluster |
|---|---|
| Phase | Phase 4 |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 157 |
| Start date | 15 June 2025 |
| Primary completion | 15 December 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across Saudi Arabia |
Drugs / interventions tested
- Midazolam (midazolam) — full drug profile →
- Propofol (Propofol) — full drug profile →
- Fentanyl (fentanyl) — full drug profile →
Conditions studied
- Deep Sedations — all drugs for Deep Sedations →
- Conscious Sedation — all drugs for Conscious Sedation →
- Colonoscopy — all drugs for Colonoscopy →
Sponsor
Qassim Health Cluster — full company profile →
Who can join
Adults 18 to 60, any sex, with Deep Sedations or Conscious Sedation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a randomized, double-blinded, prospective study which will be conducted at the Department of Gastroenterology, King Saud Hospital, Unaizah, Qassim, Saudi Arabia. This study aims to compare safety and efficacy of different types of sedation medications for elective colonoscopy. Colonoscopy is a procedure to examine and visualize the colon by a fiberoptic tube called colonoscope. Sedation helps one to relax to avoid feel any discomfort or pain during the procedure.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06763705
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Midazolam
Trials testing the same drug.
- NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
- NCT07525544 — A Study to Investigate the Safety and PK of VH4770359 in Healthy Participants · Phase 1 · not yet recruiting
- NCT07426757 — An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers · Phase 1 · not yet recruiting
- NCT07435194 — A Clinical Trial in Healthy Participants to Learn How Itraconazole Affects MK-2828 Levels and How MK-2828 Affects Midazo · Phase 1 · recruiting
- NCT07443254 — Prospective IR-led Sedation Feasibility · Phase 1, PHASE2 · recruiting
Other Qassim Health Cluster trials
Trials by the same sponsor.
- NCT05839548 — Articaine Efficacy and Safety for 3 Years Old Children · Phase 3 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06763705 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Qassim Health Cluster
- Last refreshed: 25 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06763705.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing